Induction of antigen-presenting capacity in tumor cells upon infection with non-replicating recombinant vaccinia virus encoding murine MHC class II and costimulatory molecules

Journal of Immunological Methods

Volumn 200, Issue 1-2, 1997, Pages 191-198

  Marti, Walter R ^a,b   Oertli, Daniel ^a   Meko, Jennifer B ^a   Norton, Jeffrey A ^a   Tsung, Kangla ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

artificial antigen presenting cell; I A(k); mB7 1; recombinant vaccinia virus; virology

Indexed keywords

CD4 ANTIGEN; IA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; HYBRIDOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; VACCINIA VIRUS; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; CELL LINE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; NEOPLASMS; RECOMBINANT PROTEINS; VACCINIA VIRUS;

ANIMALIA; GALLUS GALLUS; MURINAE; VACCINIA; VACCINIA VIRUS;

EID: 0031021566     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(96)00210-4     Document Type: Article

References (27)

1. Allen, P.M. and Unanue, E.R. (1984) Processing and presentation of hen egg-white lysozyme by macrophages. Immunobiology 168, 182.
2. Allen, P.M. and Unanue, E.R. (1987) Antigen processing at a moleculare level. Immunol. Adv. Exp. Med. Biol. 225, 147.
3. Andrew, M.E. (1989). Protective efficacy of a recombinant vaccinia virus in vaccinia-immune mice. Immunol. Cell Biol. 67. 339.
4. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J. Exp. Med. 181, 619.
5. + T cells. J. Immunol. 154, 4915.
6. Earl, P.L., Moss, B., Expression of proteins in mammalian cells using vaccinia. In: Ausubel, P.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G. and Smith, J.A. (Eds.) (1995) Current Protocols in Molecular Biology. Greene, New York, p. 16.15.1.
7. Falkner, F.G. and Moss, B. (1990) Transient dominant selection of recombinant vaccinia viruses. J. Virol. 64, 3108.
8. Freudenthal, P.S. and Steinmann, R.M. (1990). The distinct surface of human blood dendritic cells as observed after an improved isolation method. Proc. Natl. Acad. Sci. USA 87, 7698.
9. Galvin, F., Freeman, G.J., Razi-Wolf, Z., Hall, W., Jr., Benacerraf. B., Nadler, L. and Reiser, H. (1992) Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation. J. Immunol. 149, 3802.
10. Germain, R.N. (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287.
11. Germain, R.H. and Margulies, D.H. (1993) The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11, 403.
12. Goebel, S.J., Johnson, G.P., Perkus, M.E., Davis, S.W., Winslow, J.P. and Paoletti, E. (1990) The complete DNA sequence of vaccinia virus. Virology 179, 517.
13. Hanson, C.V., Riggs, J.L. and Lennette, E.H. (1978). Photochemical inactivation of DNA and RNA viruses by psoralen derivatives. J. Gen. Virol. 40, 345.
14. Hodge, J.W., Abrams, S., Schlom, J. and Kantor, J.A. (1994) Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res. 54, 5552.
15. Hubbe, M. and Altevogt, P. (1994) Heat-stable antigen/CD40 on mouse T lymphocytes: evidence for a costimulatory function. Eur. J. Immunol. 24, 731.
16. Janeway, Jr., C.A. and Bottomly, K. (1994) Signals and signs for lymphocyte responses. Cell 76, 275.
17. Jeltsch, J.-M. and Chambon, P. (1982) The complete nucleotide sequence of the chicken ovotransferrin mRNA. Eur. J. Biochem. 122, 291.
18. k-restricted T helper hybridomas. J. Immunol. 142, 3298.
19. Jolly, D. (1994) Viral vector systems for gene therapy. Cancer Gene Ther. 1, 51.
20. Kaye, J., Gillis, S., Mizel, S.B., Shevach, E.M., Malek, T.R., Dinarello, C.A., Lachman, L.B. and Janeway, Jr., C.A. (1984) Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J. Immunol. 133, 1339.
21. Lechler, R.I., Norcross, M.A. and Germain, R.N. (1985) Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells. J. Immunol. 135, 2914.
22. Linsley, P.S., Brady, W., Urnes, M., Grosmaire, L.S., Damle, N.K. and Ledbetter, J.A. (1991) CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174, 561.
23. Moss, B. (1991) Vaccinia virus: a tool for research and vaccine development. Science 252, 1662.
24. Schwartz, R.H. (1992) Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71, 1065.
25. Smith, G.L. and Mackett, M. (1992) The design, construction and use of vaccinia virus recombinants. In: M.M. Binns and G.L. Smith (Eds.), Recombinant Poxviruses. CRC Press, Boca Raton, FL, p. 81.
26. Tsung, K., Yim, J.H., Marti, W., Buller, R.M.L. and Norton, J.A. (1996) Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J. Virol. 70, 165.
27. Williams, I.R. and Unanue, E.R. (1991) Characterization of accessory cell costimulation of Th1 cytokine synthesis. J. Immunol. 147, 3752.